Advanced search
Publication Cover
Patient Preference and Adherence Volume 10, 2016 - Issue
Submit an article Journal homepage
178
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patients

Vera Vennedey1 Institute for Health Economics and Clinical Epidemiology, Cologne University Hospital, Cologne, GermanyCorrespondence[email protected]
,
Marion Danner1 Institute for Health Economics and Clinical Epidemiology, Cologne University Hospital, Cologne, Germany
,
Silvia MAA Evers2 Department of Health Services Research, School for Primary Care and Public Health (CAPHRI), Maastricht University, Maastricht, the Netherlands;3 Department of Public Mental Health, Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands
,
Sascha Fauser4 Department of Vitreo-Retinal Surgery, Center of Ophthalmology, Cologne University Hospital, Cologne, Germany
,
Stephanie Stock1 Institute for Health Economics and Clinical Epidemiology, Cologne University Hospital, Cologne, Germany
,
Carmen D Dirksen5 Department of Clinical Epidemiology and Medical Technology Assessment, CAPHRI, University Hospital Maastricht, Maastricht, the Netherlands
&
Mickaël Hiligsmann2 Department of Health Services Research, School for Primary Care and Public Health (CAPHRI), Maastricht University, Maastricht, the Netherlands
 show all
Pages 993-1002 | Published online: 03 Jun 2016

References

  • WongWLSuXLiXGlobal prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysisLancet Glob Health201422e106e11625104651
  • MuetherPSHermannMMKochKFauserSDelay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuityGraefes Arch Clin Exp Ophthalmol2011249563363720865421
  • RealJPGraneroGEDe SantisMORate of vision loss in neo-vascular age-related macular degeneration exploredGraefes Arch Clin Exp Ophthalmol2015253111859186525491161
  • WenzelMAuffarthGScharrerASchayanKReinhardTAmbulante und stationäre Intraokularchirurgie 2013: Ergebnisse der Umfrage von BDOC, BVA, DGII und DOG [Inpatient and outpatient intraocular surgery 2013: results of a survey among BDOC, BVA, DGII and DOG]Ophthalmo-Chirurgie201426171182 German
  • European Medicines Agency [homepage on the Internet]Summary of the European public assessment report (EPAR) for Lucentis (ranibizumab)EMA2008 [updated November 13, 2015]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000715/human_med_000890.jsp&mid=WC0b01ac058001d124Accessed March 31, 2016
  • European Medicines Agency [homepage on the Internet]Summary of the European public assessment report (EPAR) for Eylea (aflibercept)EMA2012 [updated February 4, 2016]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002392/human_med_001598.jsp&mid=WC0b01ac058001d124Accessed March 31, 2016
  • MojaLLucenteforteEKwagKHSystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationCochrane Database Syst Rev20149CD01123025220133
  • DroegeKMCaramoyAKerstenAPatient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration – monthly injections versus pro re nataGraefes Arch Clin Exp Ophthalmol20142521313423860798
  • DroegeKMMuetherPSHermannMMAdherence to ranibizumab treatment for neovascular age-related macular degeneration in real lifeGraefes Arch Clin Exp Ophthalmol201225151281128423086225
  • BridgesJFHauberABMarshallDConjoint analysis applications in health – a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceValue Health201114440341321669364
  • Reed JohnsonFLancsarEMarshallDConstructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceValue Health201316131323337210
  • CoastJAl-JanabiHSuttonEJUsing qualitative methods for attribute development for discrete choice experiments: issues and recommendationsHealth Econ201221673074121557381
  • CoastJHorrocksSDeveloping attributes and levels for discrete choice experiments using qualitative methodsJ Health Serv Res Policy2007121253017244394
  • DannerMVennedyVHiligsmannMFauserSStockSFocus Groups in Elderly Ophthalmologic Patients: Setting the Stage for Quantitative Preference ElicitationPatient201691475725726011
  • RyanMGerardKAmaya-AmayaMUsing discrete choice experiments to value health and health care11DordrechtSpringer Science & Business Media2007
  • OrmeBKGetting started with conjoint analysisMadison, WIResearch Publishers LLC2006
  • BechMGyrd-HansenDEffects coding in discrete choice experimentsHealth Econ200514101079108315852455
  • FellerWAn introduction to probability theory and its applications13rd edHoboken, NJJohn Wiley and Sons, Inc1968
  • AltmanDGBlandJMHow to obtain the P value from a confidence intervalBMJ2011343d230422803193
  • RyanMWatsonVEntwistleVRationalising the ‘irrational’: a think aloud study of discrete choice experiment responsesHealth Econ200918332133618651601
  • LancsarELouviereJDeleting ‘irrational’ responses from discrete choice experiments: a case of investigating or imposing preferences?Health Econ200615879781116615039
  • de Bekker-GrobEWDonkersBJonkerMFStolkEASample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical GuidePatient20158537338425726010
  • SackettDLRosenbergWMGrayJHaynesRBRichardsonWSEvidence based medicine: what it is and what it isn’tBMJ1996312702371728555924

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.